Literature DB >> 35841448

Screening of febrile patients with suspected malaria from the Brazilian Amazon for virus infection.

Marcus Vinícius Guimarães Lacerda1,2, Victor Hugo Aquino3, Mario Luis Garcia de Figueiredo4, Evan P Williams5, Colleen B Jonsson5, Mohd Jaseem Khan4, Márcio Roberto Teixeira Nunes6, Clayton Pereira Silva de Lima6, Luiz Tadeu Moraes Figueiredo7, Mônica Regina Farias Costa8, Maria Paula Gomes Mourão8,9.   

Abstract

Arthropod-borne viruses (arboviruses) are a significant public health threat, especially in tropical and subtropical regions. More than 150 arboviruses can cause febrile illness following infection in humans. The Brazilian Amazon region has the highest number of arboviruses detected worldwide. In addition to arboviruses, malaria, caused by Plasmodium vivax, is endemic in the Amazon. Patients with malaria and arboviral disease frequently show similar clinical presentation and laboratory findings, making the diagnosis of the cause of the infection challenging. The aim of this study was to evaluate the potential for viral infections in patients with suspected malaria but without Plasmodium infection in the Brazilian Amazon. We recruited 200 subjects with suspected malaria in Manaus, Brazil. First, we tested for arboviruses in serum samples from 124 of the 200 participants using an arbovirus DNA microarray platform, which did not detect any virus. Then, we mixed the serum samples of the other 76 participants in 10 pools and subjected them to next-generation sequencing. Analysis of the sequencing data revealed the presence of only one arbovirus (Zika virus) in one sample pool. This analysis also detected the presence of primate erythroparvovirus 1 and pegivirus C. These results suggest that arboviruses are not the most frequent viral infections in patients with suspected malaria but without Plasmodium infection in the metropolitan region of Manaus. Implementation of specific viral surveillance tests will help in the early detection of viruses with epidemic potential.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Austria, part of Springer Nature.

Entities:  

Mesh:

Year:  2022        PMID: 35841448     DOI: 10.1007/s00705-022-05514-7

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.685


  58 in total

1.  Long-term reinfection of the human genome by endogenous retroviruses.

Authors:  Robert Belshaw; Vini Pereira; Aris Katzourakis; Gillian Talbot; Jan Paces; Austin Burt; Michael Tristem
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-25       Impact factor: 11.205

2.  When fever is not malaria.

Authors:  Zeno Bisoffi; Dora Buonfrate
Journal:  Lancet Glob Health       Date:  2013-06-25       Impact factor: 26.763

3.  Erythrocyte P antigen: cellular receptor for B19 parvovirus.

Authors:  K E Brown; S M Anderson; N S Young
Journal:  Science       Date:  1993-10-01       Impact factor: 47.728

4.  GB virus C infection among young, HIV-negative injection drug users with and without hepatitis C virus infection.

Authors:  B Boodram; R C Hershow; D Klinzman; J T Stapleton
Journal:  J Viral Hepat       Date:  2011-04       Impact factor: 3.728

5.  Hepatitis G virus: prevalence and sequence analysis in blood donors of São Paulo, Brazil.

Authors:  L Bassit; B Kleter; G Ribeiro-dos-Santos; G Maertens; E Sabino; D Chamone; W Quint; A Sáez-Alquézar
Journal:  Vox Sang       Date:  1998       Impact factor: 2.144

Review 6.  Parvovirus B19 infection and systemic lupus erythematosus: Activation of an aberrant pathway?

Authors:  Spyros Aslanidis; Athina Pyrpasopoulou; Kostas Kontotasios; Stella Doumas; Chryssanthos Zamboulis
Journal:  Eur J Intern Med       Date:  2007-11-19       Impact factor: 4.487

7.  GB virus C/hepatitis G virus and TT virus infections among high risk renal transplant recipients in India.

Authors:  Priya Abraham; George T John; Sukanya Raghuraman; Sujatha Radhakrishnan; Paulose P Thomas; Chacko K Jacob; Gopalan Sridharan
Journal:  J Clin Virol       Date:  2003-09       Impact factor: 3.168

8.  The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2018 update.

Authors:  Enis Afgan; Dannon Baker; Bérénice Batut; Marius van den Beek; Dave Bouvier; Martin Cech; John Chilton; Dave Clements; Nate Coraor; Björn A Grüning; Aysam Guerler; Jennifer Hillman-Jackson; Saskia Hiltemann; Vahid Jalili; Helena Rasche; Nicola Soranzo; Jeremy Goecks; James Taylor; Anton Nekrutenko; Daniel Blankenberg
Journal:  Nucleic Acids Res       Date:  2018-07-02       Impact factor: 16.971

9.  Lying in wait: the resurgence of dengue virus after the Zika epidemic in Brazil.

Authors:  Anderson Fernandes Brito; Lais Ceschini Machado; Rachel J Oidtman; Márcio Junio Lima Siconelli; Quan Minh Tran; Joseph R Fauver; Rodrigo Dias de Oliveira Carvalho; Filipe Zimmer Dezordi; Mylena Ribeiro Pereira; Luiza Antunes de Castro-Jorge; Elaine Cristina Manini Minto; Luzia Márcia Romanholi Passos; Chaney C Kalinich; Mary E Petrone; Emma Allen; Guido Camargo España; Angkana T Huang; Derek A T Cummings; Guy Baele; Rafael Freitas Oliveira Franca; Benedito Antônio Lopes da Fonseca; T Alex Perkins; Gabriel Luz Wallau; Nathan D Grubaugh
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 17.694

10.  High proportions of asymptomatic and submicroscopic Plasmodium vivax infections in a peri-urban area of low transmission in the Brazilian Amazon.

Authors:  Anne C G Almeida; Andrea Kuehn; Arthur J M Castro; Sheila Vitor-Silva; Erick F G Figueiredo; Larissa W Brasil; Marcelo A M Brito; Vanderson S Sampaio; Quique Bassat; Ingrid Felger; Wanderli P Tadei; Wuelton M Monteiro; Ivo Mueller; Marcus V G Lacerda
Journal:  Parasit Vectors       Date:  2018-03-20       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.